Loading...

Home
ETF
MCRB

MCRB

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

MCRB News

Seres Therapeutics Reports Strong FY EPS and Cash Position

Mar 12 2026seekingalpha

Seres Therapeutics Appoints New Executive Chair and Interim CEO

Mar 02 2026seekingalpha

Seres Therapeutics Pauses SER-155 Investment Amid Funding Challenges

Feb 12 2026seekingalpha

Seres Pauses SER-155 Phase 2 Study Amid Cost-Cutting Measures

Feb 12 2026stocktwits

Seres Therapeutics Stock Declines Amid Strategic Shift

Feb 12 2026Benzinga

Seres (MCRB) Third Quarter 2025 Earnings Call Summary

Nov 06 2025NASDAQ.COM

Seres Receives Positive Input from FDA on Phase 2 Study Protocol for SER-155; Plans Workforce Reduction

Sep 23 2025NASDAQ.COM

Seres Therapeutics reduces workforce by 25% to prolong cash reserves until Q2 2026.

Sep 23 2025SeekingAlpha

Everything You Should Know About Seres Therapeutics (MCRB) Upgrade to Buy Rating

Sep 09 2025NASDAQ.COM

Biotech Stocks Soar in After-Hours Trading: CAPR and TMDX Top the List Following Trial News and Earnings Boost

Sep 09 2025NASDAQ.COM

Robinhood Shares Surge Over 7%; Check Out 20 Stocks Making Moves in Premarket Trading

Sep 08 2025Benzinga

Seres Therapeutics Rises Following News of Acquisition Proposal

Sep 08 2025SeekingAlpha

Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript

Aug 07 2025Newsfilter

Seres (MCRB) Q2 Loss Narrows 34%

Aug 07 2025NASDAQ.COM

Seres Therapeutics CEO Eric Shaff To Resign, Thomas DesRosier And Marella Thorell To Be Co-CEOs

Jul 22 2025NASDAQ.COM

This Coty Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

May 08 2025Benzinga